Compass Chiropractic and Massage

Glucosamine and Dementia Risk: What the Research Really Shows

Est. Reading: 2 minutes

Glucosamine and Dementia Risk: What the Research Really Shows

Glucosamine is a widely used dietary supplement for joint discomfort. Recent research has also explored whether its use is associated with dementia—but the findings do not show that glucosamine either causes or prevents dementia.

Why the research appears contradictory

Several large population studies have compared people who reported using glucosamine with those who did not. Some found a lower rate of certain types of dementia among users, while another large prospective study found no association. Because these studies were observational, they cannot establish that glucosamine produced either result. Supplement users may differ from nonusers in exercise, diet, income, medical care and other factors that are difficult to fully account for.

A newer University of Florida–led study examined a different question: what happens among people who already have mild cognitive impairment (MCI) or Alzheimer’s disease? Researchers combined laboratory work with a retrospective analysis of electronic health records. Documented glucosamine use was associated with faster progression from MCI to Alzheimer’s disease. However, an association in medical records does not prove that the supplement caused the progression. The authors called for prospective clinical trials, and a subsequent analysis also emphasized limitations in the mortality data.

What the studies can—and cannot—tell us

  • They do not prove that glucosamine causes dementia. The newer human findings came from retrospective health records, not a randomized trial.
  • They do not prove that glucosamine prevents dementia. Earlier reports of lower dementia rates were also observational, and results across studies have been inconsistent.
  • The populations were different. Research involving generally healthy adults cannot be directly compared with research involving people who already have MCI or Alzheimer’s disease.
  • The reason for taking glucosamine matters. Joint disease, activity level, other supplements, medications and access to health care may all influence the results.

What should glucosamine users do?

Do not start or stop a supplement solely because of a headline. If you take glucosamine—especially if you have MCI, Alzheimer’s disease, memory concerns or a complex medication list—review it with your physician or pharmacist. Bring the product label and dosage so your health professional can consider the exact formulation and your overall health.

Glucosamine’s benefit for osteoarthritis is itself uncertain. Major professional guidelines do not all agree, and results can vary by formulation. The National Center for Complementary and Integrative Health notes that glucosamine may affect blood sugar in some people and may increase bleeding risk when combined with warfarin.

Seek medical evaluation for new or worsening memory problems rather than attempting to manage them by changing supplements alone. A clinician can review medications, sleep, hearing, mood, metabolic conditions and other factors that may affect cognition.

The bottom line

Current evidence does not support the claim that glucosamine simply “causes dementia,” nor does it justify using glucosamine to prevent dementia. The newer findings raise a reasonable safety question for people who already have cognitive impairment, but clinical trials are needed before researchers can determine whether the relationship is causal.

Sources

Back To Blog
Copyright © 2026 All Rights Reserved
Call Now
Send A Text
chevron-up-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram